https://ipharmag.com/article/novartis-abogen-mrna-t-cell-engager-autoimmune-deal iPharmag en 2026-10-02T13:40:45+00:00 Novartis Bets Up to $7.8 Billion on an mRNA Drug That Turns the Body Into Its Own Antibody Factory https://ipharmag.com/article/fda-approves-autus-heart-valve-grows-with-children iPharmag en 2026-10-02T13:40:45+00:00 FDA Approves the First Heart Valve Designed to Grow With Children https://ipharmag.com/article/car-t-therapy-explained-cancer-autoimmune iPharmag en 2026-10-02T13:40:45+00:00 CAR-T Therapy Explained: How It Works, What It Treats, and Its New Role in Autoimmune Disease https://ipharmag.com/article/what-is-a-jak-inhibitor-explained-uses-side-effects iPharmag en 2026-10-01T12:41:35+00:00 What Is a JAK Inhibitor? How They Work, What They Treat, and the Risks to Know https://ipharmag.com/article/sanofi-regeneron-8b-long-acting-dupixent-successors iPharmag en 2026-10-01T12:41:35+00:00 Sanofi and Regeneron Strike an $8 Billion Deal to Build Dupixent’s Successors https://ipharmag.com/article/fda-approves-camzyos-adolescents-obstructive-hcm iPharmag en 2026-10-01T12:41:35+00:00 FDA Expands Camzyos to Teenagers With Obstructive Hypertrophic Cardiomyopathy